| Acronym |
Full Name |
Score |
Rating |
Judge me |
Search |
| IFN |
Interferon |
824 |
3 |
good
bad
|
 |
| IFN |
alpha-interferon |
31 |
6 |
good
bad
|
|
| IFN |
interferons |
28 |
7 |
good
bad
|
|
| IFN |
Gamma-interferon |
24 |
0 |
good
bad
|
|
| IFN |
interferon-gamma |
22 |
4 |
good
bad
|
|
| IFN |
interferon-alpha |
18 |
-2 |
good
bad
|
|
| IFN |
interferon alpha |
15 |
4 |
good
bad
|
|
| IFN |
I interferon |
15 |
2 |
good
bad
|
|
| IFN |
induce interferon |
12 |
1 |
good
bad
|
|
| IFN |
including interferon |
7 |
7 |
good
bad
|
|
| IFN |
induced interferon |
6 |
12 |
good
bad
|
|
| IFN |
induced by interferon |
5 |
9 |
good
bad
|
|
| IFN |
beta-Interferon |
5 |
4 |
good
bad
|
|
| IFN |
inducer of interferon |
5 |
3 |
good
bad
|
|
| IFN |
IL-4 and interferon |
5 |
1 |
good
bad
|
|
| IFN |
interferon gamma |
4 |
11 |
good
bad
|
|
| IFN |
interferon alpha/beta |
4 |
4 |
good
bad
|
|
| IFN |
induces interferon |
4 |
4 |
good
bad
|
|
| IFN |
interferon-alpha 2 |
4 |
4 |
good
bad
|
|
| IFN |
interleukin (IL)-2 and interferon |
4 |
0 |
good
bad
|
|
| IFN |
interleukin (IL)-12 and interferon |
3 |
8 |
good
bad
|
|
| IFN |
an interferon |
3 |
6 |
good
bad
|
|
| IFN |
interferon alpha-2a |
3 |
6 |
good
bad
|
|
| IFN |
alpha/beta-interferon |
3 |
5 |
good
bad
|
|
| IFN |
interleukin-2 (IL-2) and interferon |
3 |
5 |
good
bad
|
|
| IFN |
interferon alpha-2b |
3 |
4 |
good
bad
|
|
| IFN |
in vitro interferon |
3 |
4 |
good
bad
|
|
| IFN |
interferon-alpha-2b |
3 |
4 |
good
bad
|
|
| IFN |
Interferon alpha 2b |
3 |
3 |
good
bad
|
|
| IFN |
alpha-2b-interferon |
3 |
3 |
good
bad
|
|
| IFN |
anti-interferon |
3 |
3 |
good
bad
|
|
| IFN |
inhibitory effects of interferon |
3 |
2 |
good
bad
|
|
| IFN |
interferon alfa-2a |
3 |
2 |
good
bad
|
|
| IFN |
in interferon |
3 |
2 |
good
bad
|
|
| IFN |
I interferons |
3 |
1 |
good
bad
|
|
| IFN |
induction of interferon |
3 |
1 |
good
bad
|
|
| IFN |
interferon-alpha 2a |
3 |
-1 |
good
bad
|
|
| IFN |
interferon alfa-2b |
3 |
-2 |
good
bad
|
|
| IFN |
in response to interferon |
2 |
13 |
good
bad
|
|
| IFN |
involved in interferon |
2 |
8 |
good
bad
|
|
| IFN |
Interleukin (IL)-18 induces interferon |
2 |
8 |
good
bad
|
|
| IFN |
interferon alpha2a |
2 |
7 |
good
bad
|
|
| IFN |
inhibits the interferon |
2 |
5 |
good
bad
|
|
| IFN |
intramuscular injection of interferon |
2 |
5 |
good
bad
|
|
| IFN |
interferon alfa 2b |
2 |
5 |
good
bad
|
|
| IFN |
(NK)-interferon |
2 |
4 |
good
bad
|
|
| IFN |
interleukin-2 (IL-2) and interferon-alpha |
2 |
4 |
good
bad
|
|
| IFN |
IL-10, interferon |
2 |
3 |
good
bad
|
|
| IFN |
Interleukin (IL)-18 is an interferon |
2 |
2 |
good
bad
|
|
| IFN |
interleukin (IL)-4 and interferon |
2 |
0 |
good
bad
|
|
| IFN |
include the alpha- and beta-interferon |
1 |
16 |
good
bad
|
|
| IFN |
including production of interferon |
1 |
12 |
good
bad
|
|
| IFN |
Interleukin-1 (IL-1) and interferon-alpha |
1 |
11 |
good
bad
|
|
| IFN |
immune (IFN-gamma) interferon |
1 |
11 |
good
bad
|
|
| IFN |
I and II interferons |
1 |
10 |
good
bad
|
|
| IFN |
interferon alpha A/D |
1 |
10 |
good
bad
|
|
| IFN |
induced high levels of interferon |
1 |
10 |
good
bad
|
|
| IFN |
influence of gamma- and alpha-interferon |
1 |
9 |
good
bad
|
|
| IFN |
infection progressed coded for interferon |
1 |
9 |
good
bad
|
|
| IFN |
5-FU/alpha-interferon |
1 |
9 |
good
bad
|
|
| IFN |
(5-FU)-interferon-alpha-2b |
1 |
8 |
good
bad
|
|
| IFN |
in vitro with interferon |
1 |
8 |
good
bad
|
|
| IFN |
initial treatment with interferon alpha-2 |
1 |
8 |
good
bad
|
|
| IFN |
initial onset of virus-specific interferon |
1 |
8 |
good
bad
|
|
| IFN |
intraventricular alpha-interferon |
1 |
8 |
good
bad
|
|
| IFN |
IFN-alphabeta |
1 |
8 |
good
bad
|
|
| IFN |
intereferon |
1 |
8 |
good
bad
|
|
| IFN |
IL-6 and interferon |
1 |
8 |
good
bad
|
|
| IFN |
mediated by interferon |
1 |
7 |
good
bad
|
|
| IFN |
interleukin-2 (IL-2) combined with alpha-interferon |
1 |
7 |
good
bad
|
|
| IFN |
interleukin (IL)-10 and interferon |
1 |
7 |
good
bad
|
|
| IFN |
interferon-alpha A/D |
1 |
7 |
good
bad
|
|
| IFN |
induced with interferon |
1 |
7 |
good
bad
|
|
| IFN |
interleukin 2 (IL-2) and interferon |
1 |
7 |
good
bad
|
|
| IFN |
investigating the mechanism of interferon |
1 |
7 |
good
bad
|
|
| IFN |
injections of lymphoblastoid alpha-interferon |
1 |
7 |
good
bad
|
|
| IFN |
inhibit interferon |
1 |
7 |
good
bad
|
|
| IFN |
induction of human leukocyte interferon |
1 |
7 |
good
bad
|
|
| IFN |
in predicting interferon |
1 |
7 |
good
bad
|
|
| IFN |
IL-12 and interferon-gamma |
1 |
7 |
good
bad
|
|
| IFN |
in whom alpha-interferon |
1 |
7 |
good
bad
|
|
| IFN |
alfa-2a-interferon |
1 |
7 |
good
bad
|
|
| IFN |
interferon alpha A |
1 |
6 |
good
bad
|
|
| IFN |
including interferons |
1 |
6 |
good
bad
|
|
| IFN |
investigate the efficacy of interferon alfa-2b |
1 |
6 |
good
bad
|
|
| IFN |
influence of alpha-interferon |
1 |
6 |
good
bad
|
|
| IFN |
interleukin-2 and interferon |
1 |
6 |
good
bad
|
|
| IFN |
inhibition assay of canine interferon |
1 |
6 |
good
bad
|
|
| IFN |
intracellular domains of the interferon |
1 |
6 |
good
bad
|
|
| IFN |
identified interferon |
1 |
6 |
good
bad
|
|
| IFN |
investigated the co-delivery of inteferon |
1 |
6 |
good
bad
|
|
| IFN |
gondii-infected anti-interferon |
1 |
6 |
good
bad
|
|
| IFN |
immunoassay the effect of interferon |
1 |
6 |
good
bad
|
|
| IFN |
independent of endogenously produced interferon-alpha/beta |
1 |
6 |
good
bad
|
|
| IFN |
infection who responded to interferon |
1 |
6 |
good
bad
|
|
| IFN |
integrated human beta-interferon |
1 |
6 |
good
bad
|
|
| IFN |
inhibited by antibodies to interferon |
1 |
6 |
good
bad
|
|
| IFN |
IL-1beta and IL-1beta/interferon |
1 |
6 |
good
bad
|
|
| IFN |
identification of a putative interferon |
1 |
5 |
good
bad
|
|
| IFN |
alpha-interferon-2b |
1 |
5 |
good
bad
|
|
| IFN |
interleukin-1 (IL-1) on interferon-gamma |
1 |
5 |
good
bad
|
|
| IFN |
influenced the resistance to exogenous |
1 |
5 |
good
bad
|
|
| IFN |
inhibit MHC transcription and interferon |
1 |
5 |
good
bad
|
|
| IFN |
inhibit the synthesis of interferon |
1 |
5 |
good
bad
|
|
| IFN |
IL-2 + interferon alpha |
1 |
5 |
good
bad
|
|
| IFN |
implementation of interferon |
1 |
5 |
good
bad
|
|
| IFN |
interferon-a2b |
1 |
5 |
good
bad
|
|
| IFN |
interferon-alfa-2b |
1 |
5 |
good
bad
|
|
| IFN |
in combination with interferon |
1 |
5 |
good
bad
|
|
| IFN |
IL-13 and interferon |
1 |
5 |
good
bad
|
|
| IFN |
interferon-alpha 2b |
1 |
5 |
good
bad
|
|
| IFN |
IFN-alpha 2b |
1 |
5 |
good
bad
|
|
| IFN |
inhibitory effect of interferon |
1 |
5 |
good
bad
|
|
| IFN |
interferon-alpha/beta |
1 |
5 |
good
bad
|
|
| IFN |
including alpha and beta interferon |
1 |
5 |
good
bad
|
|
| IFN |
well-studied interferon |
1 |
5 |
good
bad
|
|
| IFN |
in type I interferon |
1 |
5 |
good
bad
|
|
| IFN |
induced in interferon |
1 |
5 |
good
bad
|
|
| IFN |
involvement of endogenous interferon |
1 |
5 |
good
bad
|
|
| IFN |
Intravenous administration of an interferon |
1 |
5 |
good
bad
|
|
| IFN |
inducer of interferons alpha and beta |
1 |
5 |
good
bad
|
|
| IFN |
investigational agents include alpha-interferon |
1 |
5 |
good
bad
|
|
| IFN |
increase of interferon |
1 |
5 |
good
bad
|
|
| IFN |
induction of an interferon |
1 |
5 |
good
bad
|
|
| IFN |
induced mRNA for interferon |
1 |
5 |
good
bad
|
|
| IFN |
infants who have received interferon alpha-2a |
1 |
5 |
good
bad
|
|
| IFN |
infections with single interferons |
1 |
5 |
good
bad
|
|
| IFN |
infection through interferon |
1 |
5 |
good
bad
|
|
| IFN |
increase in circulating interferon |
1 |
4 |
good
bad
|
|
| IFN |
interleukin (IL)-12-induced production of interferon |
1 |
4 |
good
bad
|
|
| IFN |
intralesional interferon |
1 |
4 |
good
bad
|
|
| IFN |
immune interferon |
1 |
4 |
good
bad
|
|
| IFN |
IL4 and interferon |
1 |
4 |
good
bad
|
|
| IFN |
indicated that interferon |
1 |
4 |
good
bad
|
|
| IFN |
related to interferon |
1 |
4 |
good
bad
|
|
| IFN |
interferon-a |
1 |
4 |
good
bad
|
|
| IFN |
immunochemotherapy [interferon |
1 |
4 |
good
bad
|
|
| IFN |
interferon alpha and gamma |
1 |
4 |
good
bad
|
|
| IFN |
interferon alfa |
1 |
4 |
good
bad
|
|
| IFN |
IL10, interferon |
1 |
4 |
good
bad
|
|
| IFN |
in myeloma patients Interferon |
1 |
4 |
good
bad
|
|
| IFN |
interleukin (IL)-1beta and interferon |
1 |
4 |
good
bad
|
|
| IFN |
Y-interferon |
1 |
4 |
good
bad
|
|
| IFN |
influence the efficacy of interferon |
1 |
4 |
good
bad
|
|
| IFN |
inhibited interferon |
1 |
4 |
good
bad
|
|
| IFN |
infected cells and interferon |
1 |
4 |
good
bad
|
|
| IFN |
II antigens on interferon |
1 |
4 |
good
bad
|
|
| IFN |
immune system and serum interferon |
1 |
4 |
good
bad
|
|
| IFN |
investigated as interferon |
1 |
4 |
good
bad
|
|
| IFN |
interleukin-2 (IL-2) and interferon alfa-2a |
1 |
3 |
good
bad
|
|
| IFN |
interleukin 2 (IL-2) and interferon gamma |
1 |
3 |
good
bad
|
|
| IFN |
IL-12 and interferon |
1 |
3 |
good
bad
|
|
| IFN |
interleukin-2 (IL-2) and gamma-interferon |
1 |
3 |
good
bad
|
|
| IFN |
Interleukin 2 (IL-2) and interferon-gamma |
1 |
3 |
good
bad
|
|
| IFN |
intra-cellular interferon |
1 |
3 |
good
bad
|
|
| IFN |
intracerebral delivery of interferon |
1 |
3 |
good
bad
|
|
| IFN |
(HBV)-infected hepatocytes with lymphoblastoid alpha-interferon |
1 |
3 |
good
bad
|
|
| IFN |
interleukin 2 (IL2) and interferon |
1 |
3 |
good
bad
|
|
| IFN |
III melanoma who received |
1 |
3 |
good
bad
|
|
| IFN |
induced by interferon gamma |
1 |
3 |
good
bad
|
|
| IFN |
injection schedule of interferon |
1 |
3 |
good
bad
|
|
| IFN |
induces high frequencies of interferon |
1 |
3 |
good
bad
|
|
| IFN |
injected with recombinant interferon |
1 |
3 |
good
bad
|
|
| IFN |
induction of IL-12-mediated interferon |
1 |
3 |
good
bad
|
|
| IFN |
infection is treated with interferon |
1 |
3 |
good
bad
|
|
| IFN |
infusion and alpha interferon |
1 |
3 |
good
bad
|
|
| IFN |
inhibited alpha/beta-interferon |
1 |
3 |
good
bad
|
|
| IFN |
inhibit the secretion of interferon |
1 |
3 |
good
bad
|
|
| IFN |
insufficiency with nephrotic-range proteinuria during alpha-interferon |
1 |
3 |
good
bad
|
|
| IFN |
alpha-interferon 2a |
1 |
3 |
good
bad
|
|
| IFN |
incubated with interferon |
1 |
3 |
good
bad
|
|
| IFN |
including interferon-beta |
1 |
3 |
good
bad
|
|
| IFN |
gamma-interferons |
1 |
2 |
good
bad
|
|
| IFN |
influence of interferon-alpha-2b |
1 |
2 |
good
bad
|
|
| IFN |
induced by exogenous interferon |
1 |
2 |
good
bad
|
|
| IFN |
treated with interferon gamma |
1 |
2 |
good
bad
|
|
| IFN |
intrauterine devices (IUDs) release interferon |
1 |
2 |
good
bad
|
|
| IFN |
inherent variations in their interferon |
1 |
2 |
good
bad
|
|
| IFN |
induce production of immune interferon |
1 |
2 |
good
bad
|
|
| IFN |
inhibit in vitro the interferon |
1 |
2 |
good
bad
|
|
| IFN |
alpha-interferons |
1 |
2 |
good
bad
|
|
| IFN |
omega-interferon |
1 |
2 |
good
bad
|
|
| IFN |
induced by inferferon |
1 |
2 |
good
bad
|
|
| IFN |
inducing the production of interferon |
1 |
2 |
good
bad
|
|
| IFN |
inducibility by interferon |
1 |
2 |
good
bad
|
|
| IFN |
intracellular enzyme induced by interferon |
1 |
2 |
good
bad
|
|
| IFN |
induced the production of interferon |
1 |
2 |
good
bad
|
|
| IFN |
investigate the expression of interferon |
1 |
2 |
good
bad
|
|
| IFN |
125I-interferon |
1 |
2 |
good
bad
|
|
| IFN |
interleukin (IL)-8 and interferon |
1 |
2 |
good
bad
|
|
| IFN |
ICV microinfusion of interferon |
1 |
2 |
good
bad
|
|
| IFN |
interleukin (IL)-4 and anti-interferon |
1 |
2 |
good
bad
|
|
| IFN |
interferon monotherapy |
1 |
2 |
good
bad
|
|
| IFN |
IL-2 and interferon alpha |
1 |
2 |
good
bad
|
|
| IFN |
Interferon alfa 2a |
1 |
2 |
good
bad
|
|
| IFN |
inhibits the established interferon |
1 |
2 |
good
bad
|
|
| IFN |
interferon alpha or gamma |
1 |
2 |
good
bad
|
|
| IFN |
important component of interferon |
1 |
2 |
good
bad
|
|
| IFN |
Interleukin-2 (IL-2) or/and interferon |
1 |
2 |
good
bad
|
|
| IFN |
in combination with interferon-alpha |
1 |
1 |
good
bad
|
|
| IFN |
induced interferon-alpha |
1 |
1 |
good
bad
|
|
| IFN |
interferon activity |
1 |
1 |
good
bad
|
|
| IFN |
in regulating interferon |
1 |
1 |
good
bad
|
|
| IFN |
inducers of interferon |
1 |
1 |
good
bad
|
|
| IFN |
IL-17 and interferon |
1 |
1 |
good
bad
|
|
| IFN |
interdict interferon |
1 |
1 |
good
bad
|
|
| IFN |
induced high titers of interferon |
1 |
1 |
good
bad
|
|
| IFN |
IL-12-treated mice was abrogated by anti-interferon |
1 |
1 |
good
bad
|
|
| IFN |
intranasal interferon |
1 |
1 |
good
bad
|
|
| IFN |
alpha-2a-interferon |
1 |
1 |
good
bad
|
|
| IFN |
IFN-alpha |
1 |
1 |
good
bad
|
|
| IFN |
induce interferons |
1 |
1 |
good
bad
|
|
| IFN |
role in interferon |
1 |
1 |
good
bad
|
|
| IFN |
IL-5 and interferon |
1 |
1 |
good
bad
|
|
| IFN |
Interferon alpha2-b |
1 |
0 |
good
bad
|
|
| IFN |
interleukin 2 and interferon |
1 |
0 |
good
bad
|
|
| IFN |
Immunotherapy with interferon |
1 |
0 |
good
bad
|
|
| IFN |
interleukin (IL)-1beta + interferon |
1 |
0 |
good
bad
|
|
| IFN |
interferon production |
1 |
0 |
good
bad
|
|
| IFN |
inhibitory effects on interferon |
1 |
0 |
good
bad
|
|
| IFN |
including an interferon |
1 |
0 |
good
bad
|
|
| IFN |
independent of interferon |
1 |
0 |
good
bad
|
|
| IFN |
inflammatory foci-positive (IFP) and inflammatory foci-negative |
1 |
0 |
good
bad
|
|
| IFN |
IL-10 and interferon |
1 |
0 |
good
bad
|
|
| IFN |
IL 12 and interferon |
1 |
-1 |
good
bad
|
|
| IFN |
infected mice with an interferon |
1 |
-1 |
good
bad
|
|
| IFN |
incidence of anti-interferon |
1 |
-1 |
good
bad
|
|
| IFN |
interrelationship to in vitro interferon |
1 |
-1 |
good
bad
|
|
| IFN |
interleukin-2 (rIL-2) and alpha-interferon |
1 |
-1 |
good
bad
|
|
| IFN |
initially described as interferon |
1 |
-1 |
good
bad
|
|
| IFN |
interfascicular neurons |
1 |
-1 |
good
bad
|
|
| IFN |
inhibitor of the interferon |
1 |
-1 |
good
bad
|
|
| IFN |
in induction of interferon |
1 |
-2 |
good
bad
|
|